These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8113984

  • 21. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran L, Przegalinski E, Kostowski W, Krzascik P, Chizh B, Headley PM.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [Abstract] [Full Text] [Related]

  • 22. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y, Komiyama C, Makino M, Takasuna K, Takazawa A, Sakurada S.
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea.
    Tantisira B, Tantisira MH, Patarapanich C, Sooksawate T, Chunngam T.
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228
    [Abstract] [Full Text] [Related]

  • 25. N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats.
    Witkin JM, Cerne R, Newman AH, Izenwasser S, Smith JL, Tortella FC.
    Pharmacol Biochem Behav; 2021 Apr; 203():173154. PubMed ID: 33609599
    [Abstract] [Full Text] [Related]

  • 26. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
    Beekman M, Ungard JT, Gasior M, Carter RB, Dijkstra D, Goldberg SR, Witkin JM.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
    [Abstract] [Full Text] [Related]

  • 27. Neuroprotective profile of dextromethorphan in an experimental model of penetrating ballistic-like brain injury.
    Shear DA, Williams AJ, Sharrow K, Lu XC, Tortella FC.
    Pharmacol Biochem Behav; 2009 Nov; 94(1):56-62. PubMed ID: 19619574
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M, Wielosz M, Czuczwar SJ.
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of dextromethorphan and dextrorphan as a preventive treatment of soman toxicity in mice.
    Dematteis M, Mallaret M, Baubichon D, Pernot-Marino I, Lallement G.
    Neurosci Lett; 1997 Oct 03; 234(2-3):91-4. PubMed ID: 9364505
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage.
    Kadriu B, Guidotti A, Costa E, Auta J.
    Toxicology; 2009 Feb 27; 256(3):164-74. PubMed ID: 19111886
    [Abstract] [Full Text] [Related]

  • 35. Effects of dextrorotatory morphinans on alpha3beta4 nicotinic acetylcholine receptors expressed in Xenopus oocytes.
    Lee JH, Shin EJ, Jeong SM, Kim JH, Lee BH, Yoon IS, Lee JH, Choi SH, Lee SM, Lee PH, Kim HC, Nah SY.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):85-92. PubMed ID: 16563374
    [Abstract] [Full Text] [Related]

  • 36. Dextromethorphan alters the reinforcing effect of cocaine in the rat.
    Kim HC, Park BK, Hong SY, Jhoo WK.
    Methods Find Exp Clin Pharmacol; 1997 Nov 24; 19(9):627-31. PubMed ID: 9500126
    [Abstract] [Full Text] [Related]

  • 37. [S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties.
    Palmer GC, Murray RJ, Cramer CL, Stagnitto ML, Knowles MK, Freedman LR, Eismann MS, Mahmood N, Balestra M, Borrelli AR, Hudzik TJ, McCarthy DJ.
    J Pharmacol Exp Ther; 1999 Jan 24; 288(1):121-32. PubMed ID: 9862762
    [Abstract] [Full Text] [Related]

  • 38. Effect of celecoxib on anticonvulsant activity of carbamazepine against maximal electroshock-induced convulsions in mice.
    Tayal V, Kalra BS, Chawla S.
    Methods Find Exp Clin Pharmacol; 2008 Dec 24; 30(10):727-30. PubMed ID: 19271020
    [Abstract] [Full Text] [Related]

  • 39. Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
    Yamashita H, Ohno K, Amada Y, Hattori H, Ozawa-Funatsu Y, Toya T, Inami H, Shishikura J, Sakamoto S, Okada M, Yamaguchi T.
    J Pharmacol Exp Ther; 2004 Jan 24; 308(1):127-33. PubMed ID: 14569061
    [Abstract] [Full Text] [Related]

  • 40. Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan.
    Lin TY, Lu CW, Wang SJ.
    Neurochem Int; 2009 Jul 24; 54(8):526-34. PubMed ID: 19428798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.